Digital Therapeutics - Japan

Japan

Highlights

Revenue in the Digital Therapeutics market is projected to reach US$0.72 in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1,800.00%, resulting in a projected market volume of US$1.79m by 2029.
User penetration will be 0.08% in 2024 and is expected to hit 0.20% by 2029.
The average revenue per user (ARPU) is expected to amount to US$0.00.
In global comparison, most revenue will be generated United States (US$3.15k in 2024).

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

Japan is experiencing a significant growth in the Digital Therapeutics market, particularly in the sub-markets of Diabetes care, Mental & Behavioral health, Cardiovascular Health, and Musculoskeletal Health.

Customer preferences: Japanese consumers are increasingly turning to Digital Therapeutics products to manage their health conditions due to the convenience and accessibility they offer. The tech-savvy population in Japan values innovative solutions that can provide personalized and effective healthcare support.

Trends in the market: In Japan, there is a growing trend towards the adoption of Digital Therapeutics for managing chronic conditions such as diabetes, mental health disorders, cardiovascular issues, and musculoskeletal problems. The emphasis on preventive healthcare and self-management aligns with the benefits offered by these digital solutions. Additionally, the aging population in Japan is driving the demand for digital tools that can help monitor and improve health outcomes.

Local special circumstances: One of the unique aspects of the Japanese market is the strong focus on precision and attention to detail, which is reflected in the development of Digital Therapeutics products. Japanese companies are known for their high-quality healthcare solutions, and this reputation extends to the digital health sector as well. The regulatory environment in Japan also plays a crucial role in shaping the Digital Therapeutics market, ensuring that products meet stringent standards for safety and efficacy.

Underlying macroeconomic factors: The increasing healthcare costs in Japan, coupled with the need to address the healthcare needs of an aging population, are driving the adoption of Digital Therapeutics as a cost-effective and efficient solution. The government's initiatives to promote digital health technologies further support the growth of the market. Additionally, the strong technological infrastructure in Japan and the willingness of healthcare providers to integrate digital solutions into their practices contribute to the expansion of the Digital Therapeutics market in the country.

Data coverage:

The data encompasses B2C enterprises. Figures are based on revenues and user data of relevant mobile applications and consumer electronics companies.

Modeling approach / Market size:

Market sizes are determined through a combined top-down and bottom-up approach, building on a specific rationale for each market segment. As a basis for evaluating markets, we use annual financial reports of key players, industry reports, third-party reports, and survey results from primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as GDP, population, internet penetration, smartphone penetration, consumer spending, and healthcare spending. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, the S-curve function and exponential trend smoothing are well suited for forecasting digital products and services due to the non-linear growth of technology adoption.

Additional notes:

The market is updated twice a year in case market dynamics change. The impact of the COVID-19 pandemic and the Russia-Ukraine war is considered at a country-specific level.